You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 3, March 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Early-Onset Alcoholics Have Lower Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid Levels Than Late-Onset Alcoholics

Marie-Lourdes Füs-Aime, MD; Michael J. Eckardt, PhD; David T. George, MD; Gerald L. Brown, MD; Ivan Mefford, PhD; Markku Linnoila, MD, PhD

Arch Gen Psychiatry. 1996;53(3):211-216.


Abstract

Background
We investigated the interrelationships of age at onset of excessive alcohol consumption, family history of alcoholism, psychiatric comorbidity, and cerebrospinal fluid monoamine metabolite concentrations in abstinent, treatment-seeking alcoholics.

Methods
We studied 131 recently abstinent alcoholics. Supervised abstinence was maintained on a research ward at the National Institutes of Health Clinical Center for a minimum of 3 weeks. All alcoholics received a low-monoamine diet for a minimum of 3 days before lumbar puncture. Lumbar punctures were performed in the morning after an overnight fast. Monoamine metabolites and tryptophan in cerebrospinal fluid were quantified with liquid chromatography by means of electrochemical detection. Psychiatric diagnoses were established from blind-rated Schedule for Affective Disorders and Schizophrenia-Lifetime version interviews administered by a research social worker. Severity and age at onset of excessive alcohol consumption were documented with a structured lifetime drinking history questionnaire and with selected alcoholism screening questionnaires (CAGE and Michigan Alcoholism Screening Test). Family history of alcoholism was obtained from the probands.

Results
A majority of the treatment-seeking, primarily white male alcoholics had a lifetime history of psychiatric disorders other than alcoholism. None fulfilled criteria for antisocial personality disorder. Early-onset alcoholics (onset of excessive consumption before 25 years of age) had a more severe course of alcoholism and lower mean cerebrospinal fluid 5-hydroxyindoleacetic acid concentration than late-onset alcoholics. Patients who reported both parents to be alcoholics had particularly low mean cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan concentrations.

Conclusion
Among treatment-seeking alcoholics, early age at onset is generally associated with a more severe course of alcoholism and lower cerebrospinal fluid 5-hydroxyindoleacetic acid concentration.



Author Affiliations

From the Laboratory of Clinical Studies, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism (Drs Fils-Aime, Eckardt, George, Brown, and Linnoila), and the Laboratory of Clinical Science, National institute of Mental Health (Dr Mefford), Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Haplotype-Based Linkage of Tryptophan Hydroxylase 2 to Suicide Attempt, Major Depression, and Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid in 4 Populations
Zhou et al.
Arch Gen Psychiatry 2005;62:1109-1118.
ABSTRACT | FULL TEXT  

PHARMACOTHERAPEUTIC TRIALS IN ADOLESCENT ALCOHOL USE DISORDERS: OPPORTUNITIES AND CHALLENGES
Dawes and Johnson
Alcohol Alcohol 2004;39:166-177.
ABSTRACT | FULL TEXT  

NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma et al.
Alcohol Alcohol 2002;37:522-533.
ABSTRACT | FULL TEXT  

Ondansetron for Reduction of Drinking Among Biologically Predisposed Alcoholic Patients: A Randomized Controlled Trial
Johnson et al.
JAMA 2000;284:963-971.
ABSTRACT | FULL TEXT  

Antisocial and Psychopathic Personality Disorders: Causes, Course, and Remission--A Review Article
Martens
Int J Offender Ther Comp Criminol 2000;44:406-430.
ABSTRACT  

PLATELET SEROTONIN UPTAKE IS HIGHER IN EARLY-ONSET THAN IN LATE-ONSET ALCOHOLICS
Javors et al.
Alcohol Alcohol 2000;35:390-393.
ABSTRACT | FULL TEXT  

ONE HUNDRED YEARS OF ALCOHOLISM: THE TWENTIETH CENTURY
Mann et al.
Alcohol Alcohol 2000;35:10-15.
ABSTRACT | FULL TEXT  

Behavioral Disinhibition Induced by Tryptophan Depletion in Nonalcoholic Young Men With Multigenerational Family Histories of Paternal Alcoholism
LeMarquand et al.
Am. J. Psychiatry 1999;156:1771-1779.
ABSTRACT | FULL TEXT  

TRAIT MARKERS FOR ALCOHOLISM: CLINICAL UTILITY
Farren and Tipton
Alcohol Alcohol 1999;34:649-665.
ABSTRACT | FULL TEXT  

Reduced Central Serotonin Transporters in Alcoholism
Heinz et al.
Am. J. Psychiatry 1998;155:1544-1549.
ABSTRACT | FULL TEXT  

Linkage of Antisocial Alcoholism to the Serotonin 5-HT1B Receptor Gene in 2 Populations
Lappalainen et al.
Arch Gen Psychiatry 1998;55:989-994.
ABSTRACT | FULL TEXT  

In Vivo Association Between Alcohol Intoxication, Aggression, and Serotonin Transporter Availability in Nonhuman Primates
Heinz et al.
Am. J. Psychiatry 1998;155:1023-1028.
ABSTRACT | FULL TEXT  

A Tryptophan Hydroxylase Gene Marker for Suicidality and Alcoholism
Nielsen et al.
Arch Gen Psychiatry 1998;55:593-602.
ABSTRACT | FULL TEXT  

Alcohol Research: At the Cutting Edge
Gordis
Arch Gen Psychiatry 1996;53:199-201.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.